Covid-19: A Formidable Challenge to the Healthcare System

Coronaviruses are important disease causing animal pathogen and recently with the mutations has resulted into the infection in humans. Beta type of corona virus a subgenus cause severe acute respiratory syndrome. Older patients with comorbid conditions including pulmonary disease, cardiac disease, kidney disease, diabetes, and hypertension have been associated with fatality. More than 2.06 million cases have been reported in 212 countries/regions, resulting in more than 137,108 fatalities across the world. The COVID-19 infection is characterized by respiratory symptoms like cough, pneumonia symptoms, gastrointestinal symptoms, high fever etc. At present there is no treatment or drug available for the disease and its changing structure and infection symptoms is posing a challenge for pharmaceutical and biomedical industry. The present review article highlights the on-going researches on pathogenesis, clinical characteristics of COVID 19.